autumn newsletter


In This Issue:

  • Overview: Alzheimer’s Association International Conference (AAIC) 2023
  • Highlights from the Alzheimer’s Association 2023 Facts and Figures
  • New Addition to the Easton Center
  • Clinical Trials
  • Upcoming Events

The Mary S. Easton Center for Alzheimer’s Research and Care at UCLA has very active teams working on basic research, drug discovery, biomarkers for early diagnosis and clinical activity including clinical trials, cognitive testing, and patient care.

Overview: Alzheimer’s Association International Conference (AAIC) 2023

The referenced media source is missing and needs to be re-embedded.

By: Timothy Chang, MD, PhD, Assistant Professor and Augustus S. Rose Chair in Neurology, and Samantha Shah, Project Manager, Chang Lab

New research presented at the Alzheimer's Association International Conference (AAIC) 2023 covered various aspects of Alzheimer's disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk factors for Alzheimer's and other dementias. This year's conference was held both virtually and in-person in Amsterdam, Netherlands, attracting over 10,000 attendees and featuring more than 3,000 scientific presentations. Easton Center faculty Drs. Keith Vossel, Timothy Chang, Kacie Deters, Daniel Silverman, Maryam Beigi, Elizabeth Rose Mayeda, Susan Bookheimer, and Yeonsu Song presented research findings at AAIC 2023.

The conference unveiled the first-ever nationwide estimates of Alzheimer's prevalence at the county level in the United States. Researchers from Rush University Medical Center revealed that the eastern and southeastern regions of the U.S. have the highest prevalence of Alzheimer's dementia, likely due to higher percentages of older individuals and those from higher-risk groups. This information can guide resource allocation for public health programs in affected regions.


Continue reading the article.